Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Amyotrophic lateral sclerosis Stories

2013-12-06 08:24:19

Collaboration to Explore Recombinant Human-Derived Monoclonal Antibodies Targeting Misfolded SOD1 CAMBRIDGE, Mass., Dec. 6, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease. The research partnership will explore a human monoclonal antibody...

Study Explains Why Promising Dementia Drugs Failed In Clinical Trials
2013-12-05 19:34:38

Cell Press Alzheimer's disease is the most common cause of dementia among older people, yet there currently are no effective drugs to stop, slow or prevent disease progression. A study online December 5th in the ISSCR's journal Stem Cell Reports, published by Cell Press, provide interesting clues on why non-steroidal anti-inflammatory drugs (NSAIDs), which have successfully treated molecular signs of Alzheimer's disease in cell and animal models, eventually failed in clinical studies....

2013-11-27 23:29:09

MMTR Health Inc. Physiologist, Terry Moore says treatment of concussions is complex but new research is explaining the relationships of previously unrecognized symptoms. Guelph, ON, Canada (PRWEB) November 27, 2013 Information on concussions is rising exponentially as we learn how many occur to how often and the dramatic costs to the medical systems in North America alone. But, until recently, knowledge was lacking for those suffering with persistent symptoms. Terry Moore, a Guelph,...

Study Sheds Light On Treatment For Parkinson's Disease
2013-11-25 07:02:43

NIH/National Institute of Neurological Disorders and Stroke Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson's disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body. "We discovered a network of genes that may regulate the disposal of dysfunctional...

2013-11-19 08:29:25

Non-Profit Leader Joins with Industry Innovator to Study Cancer Therapies for Devastating Brain Disease NEW YORK, Nov. 19, 2013 /PRNewswire/ -- Project A.L.S. today announced an agreement with Eli Lilly and Company aimed at helping to accelerate the development of potential therapies for the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. As part of the agreement, Project A.L.S. will study molecules developed and studied...

2013-11-12 16:26:46

ROCKVILLE, Md., Nov. 12, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported financial results for the three months and nine months ended September 30, 2013 and provided a business and clinical update. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) "The Company reached several major milestones in the third quarter. We completed patient dosing in our Phase Ib trial to treat major depressive disorder with NSI-189, our lead small molecule compound....

2013-11-12 08:34:21

Approach Selectively Represses Only the Disease-Causing Gene Resulting in Statistically Significant Effects on Symptoms and Other Biomarkers of Disease in Animal Models RICHMOND, Calif., Nov. 12, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that positive preclinical data from their joint program with Shire plc to develop a novel ZFP Therapeutic(®) approach to Huntington's disease (HD) were presented at the 2013 Annual Meeting of the Society for...

Potential Link Between Fungus And Parkinson’s Disease Discovered
2013-11-12 07:11:49

redOrbit Staff & Wire Reports - Your Universe Online An organic compound that is often emitted by fungi has been found to cause symptoms of Parkinson’s disease in fruit flies, and could be linked to the neurodegenerative condition in humans, researchers claim in the Monday’s edition of the journal Proceedings of the National Academy of Sciences (PNAS). Arati Inamdar and Joan Bennett of Rutgers University and their colleagues report that they had discovered a link between the...

2013-11-06 23:22:35

2014 Muscle Team Gala expected to raise more than $1 million. NEW YORK, (PRWEB) November 06, 2013 Metro New York's top pro athletes will join together to put their muscle behind finding treatments and cures for muscle disease at a special kickoff event for the 17th annual New York Muscle Team® Gala on Tuesday, Nov. 19, at 6 p.m. to benefit the Muscular Dystrophy Association. The kickoff event will take place at The Lighthouse at Chelsea Piers, Pier 61 (Hudson River and 23rd...

2013-11-06 08:28:37

TARRYTOWN, N.Y. and COARSEGOLD, Calif., Nov. 6, 2013 /PRNewswire/ -- ARMGO Pharma and the Kennedy's Disease Association (KDA) today announced that a research grant has been awarded to support preclinical work on novel, orally available compounds that have potential as a novel treatment for Kennedy's Disease (also known as Spinal Bulbar Muscular Atrophy or SBMA). The project being advanced by ARMGO Pharma is focused on a novel class of small molecule drugs known as Rycals(®) which target the...